Dr. Allen L. Richards

Dr. Allen L. Richards serves as a key procurement lead at the Naval Medical Research Center, overseeing acquisitions that directly support the health and operational readiness of U.S. Navy and Marine Corps personnel. His work centers on securing advanced biomedical research capabilities, field-deployable diagnostic systems, and laboratory analytical tools critical to force health protection in austere environments. He manages complex contract actions under the Department of the Navy, ensuring alignment with strategic priorities in infectious disease detection, rapid pathogen identification, and precision monitoring technologies. His acquisitions are primarily research-driven, requiring technical rigor and compliance with federal biomedical procurement standards. Dr. Richards maintains a consistent working relationship with REES SCIENTIFIC CORPORATION, a trusted vendor specializing in laboratory instrumentation and diagnostic assay development. His procurement approach favors long-term, performance-based partnerships with contractors possessing proven expertise in clinical diagnostics and field-deployable medical technology. These collaborations are characterized by iterative technical engagement, rigorous validation protocols, and a focus on scalable solutions suitable for deployment in expeditionary and shipboard settings. Dr. Richards does not utilize socioeconomic set-asides, with 100% of his acquisitions conducted under full and open competition. This reflects a mission-driven emphasis on technical capability and rapid delivery over socioeconomic preferences, prioritizing the most qualified vendors regardless of business size or certification status. While small businesses are not formally targeted, they remain eligible and competitive in open solicitations where they demonstrate technical superiority and operational relevance. His procurement portfolio is concentrated in NAICS 621511 (Medical Laboratories) and 541712 (Research and Development in the Physical, Engineering, and Life Sciences), reflecting a deep specialization in diagnostic assay validation, pathogen detection systems, and biomedical R&D services. He routinely procures next-generation sequencing platforms, point-of-care diagnostic devices, and bioinformatics tools designed for use in low-resource or combat environments, demonstrating expertise in translational medical science and defense-relevant innovation.